For pharma reps, access to physicians continuing to drop
(HealthDay)—Physician access for pharmaceutical representatives is continuing to decline, with access restricted to some degree for more than half of physicians, according to an AccessMonitor survey published by ZS.
Sep 14, 2015
0
5